Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Alzheimer's Disease

Free Subscription Articles published in J Neurol Retrieve available abstracts of 76 articles: HTML format

Single Articles

June 2024
1. FOXE D, Irish M, Carrick J, Cheung SC, et al
   Correction to: Visuospatial working memory in behavioural variant frontotemporal dementia: a comparative analysis with Alzheimer's disease using the box task.
   J Neurol. 2024 Jun 21. doi: 10.1007/s00415-024-12483.
   PubMed    
   
   
   
2. LI KY, Chien CF, Huang LC, Lim K, et al
   Exploring the impact of 40 Hz multi-luminaire light exposure in Alzheimer's dementia: insights from a convenient sampling, non-randomized case-control study.
   J Neurol. 2024 Jun 17. doi: 10.1007/s00415-024-12486.
   PubMed     Abstract available
   
   
   May 2024
3. FOXE D, Irish M, Carrick J, Cheung SC, et al
   Visuospatial working memory in behavioural variant frontotemporal dementia: a comparative analysis with Alzheimer's disease using the box task.
   J Neurol. 2024 May 7. doi: 10.1007/s00415-024-12406.
   PubMed     Abstract available
   
   
   
4. CANU E, Rugarli G, Coraglia F, Basaia S, et al
   Real-word application of the AT(N) classification and disease-modifying treatment eligibility in a hospital-based cohort.
   J Neurol. 2024;271:2716-2729.
   PubMed     Abstract available
   
   
   April 2024
5. WANG S, Zheng X, Huang J, Liu J, et al
   Sleep characteristics and risk of Alzheimer's disease: a systematic review and meta-analysis of longitudinal studies.
   J Neurol. 2024 Apr 24. doi: 10.1007/s00415-024-12380.
   PubMed     Abstract available
   
   
   
6. ZAMBONI G, Maramotti R, Salemme S, Tondelli M, et al
   Age-specific prevalence of the different clinical presentations of AD and FTD in young-onset dementia.
   J Neurol. 2024 Apr 21. doi: 10.1007/s00415-024-12364.
   PubMed     Abstract available
   
   
   
7. GUILOFF AE, Rudge P
   Amyloid antibody therapy for early-stage Alzheimer's disease: a critical review of three recent trials.
   J Neurol. 2024 Apr 13. doi: 10.1007/s00415-024-12361.
   PubMed    
   
   
   
8. LAVROVA A, Pham NTT, Vernon CJ, Carlos AF, et al
   A multimodal clinical diagnostic approach using MRI and (18)F-FDG-PET for antemortem diagnosis of TDP-43 in cases with low-intermediate Alzheimer's disease neuropathologic changes and primary age-related tauopathy.
   J Neurol. 2024 Apr 5. doi: 10.1007/s00415-024-12312.
   PubMed     Abstract available
   
   
   
9. MENDES AJ, Ribaldi F, Lathuiliere A, Ashton NJ, et al
   Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort.
   J Neurol. 2024;271:2053-2066.
   PubMed     Abstract available
   
   
   
10. O'CONNOR A, Lyons S, Finnegan M, Walsh J, et al
    Expanding the phenotype of psychiatric-onset prodromal dementia with Lewy bodies.
    J Neurol. 2024;271:2125-2128.
    PubMed    
    
    
    
11. SARTO J, Esteller-Gauxax D, Tort-Merino A, Guillen N, et al
    Impact of demographics and comorbid conditions on plasma biomarkers concentrations and their diagnostic accuracy in a memory clinic cohort.
    J Neurol. 2024;271:1973-1984.
    PubMed     Abstract available
    
    
    March 2024
12. LANGERSCHEIDT F, Wied T, Al Kabbani MA, van Eimeren T, et al
    Genetic forms of tauopathies: inherited causes and implications of Alzheimer's disease-like TAU pathology in primary and secondary tauopathies.
    J Neurol. 2024 Mar 30. doi: 10.1007/s00415-024-12314.
    PubMed     Abstract available
    
    
    
13. SINGH NA, Graff-Radford J, Machulda MM, Carlos AF, et al
    Atypical Alzheimer's disease: new insights into an overlapping spectrum between the language and visual variants.
    J Neurol. 2024 Mar 29. doi: 10.1007/s00415-024-12297.
    PubMed     Abstract available
    
    
    
14. PENG M, Yuan S, Lu D, Ling Y, et al
    Dietary inflammatory index, genetic susceptibility and risk of incident dementia: a prospective cohort study from UK biobank.
    J Neurol. 2024;271:1286-1296.
    PubMed     Abstract available
    
    
    February 2024
15. SUBOTIC A, Gee M, Nelles K, Ba F, et al
    Gray matter loss relates to dual task gait in Lewy body disorders and aging.
    J Neurol. 2024;271:962-975.
    PubMed     Abstract available
    
    
    January 2024
16. HUANG M, Landin-Romero R, Matis S, Dalton MA, et al
    Longitudinal volumetric changes in amygdala subregions in frontotemporal dementia.
    J Neurol. 2024 Jan 24. doi: 10.1007/s00415-023-12172.
    PubMed     Abstract available
    
    
    
17. GENG C, Meng K, Tang Y
    Identifying the mediating role of inflammation on the relationship between socioeconomic status and Alzheimer's disease: a Mendelian randomization analysis and mediation analysis.
    J Neurol. 2024 Jan 22. doi: 10.1007/s00415-023-12176.
    PubMed     Abstract available
    
    
    
18. HENNEY AE, Gillespie CS, Alam U, Hydes TJ, et al
    High intake of ultra-processed food is associated with dementia in adults: a systematic review and meta-analysis of observational studies.
    J Neurol. 2024;271:198-210.
    PubMed     Abstract available
    
    
    December 2023
19. MASSA F, Martinuzzo C, Gomez de San Jose N, Pelagotti V, et al
    Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease.
    J Neurol. 2023 Dec 29. doi: 10.1007/s00415-023-12154.
    PubMed     Abstract available
    
    
    
20. RONAT L, Hanganu A, Chylinski D, Van Egroo M, et al
    Prediction of cognitive decline in healthy aging based on neuropsychiatric symptoms and PET-biomarkers of Alzheimer's disease.
    J Neurol. 2023 Dec 19. doi: 10.1007/s00415-023-12131.
    PubMed     Abstract available
    
    
    November 2023
21. ST-GEORGES MA, Wang L, Chapleau M, Migliaccio R, et al
    Social cognition and behavioral changes in patients with posterior cortical atrophy.
    J Neurol. 2023 Nov 30. doi: 10.1007/s00415-023-12089.
    PubMed     Abstract available
    
    
    
22. PEREZ-MILLAN A, Borrego-Ecija S, Falgas N, Junca-Parella J, et al
    Cortical thickness modeling and variability in Alzheimer's disease and frontotemporal dementia.
    J Neurol. 2023 Nov 27. doi: 10.1007/s00415-023-12087.
    PubMed     Abstract available
    
    
    
23. VRILLON A, Ashton NJ, Karikari TK, Gotze K, et al
    Comparison of CSF and plasma NfL and pNfH for Alzheimer's disease diagnosis: a memory clinic study.
    J Neurol. 2023 Nov 11. doi: 10.1007/s00415-023-12066.
    PubMed     Abstract available
    
    
    September 2023
24. STAM D, Rosseel S, De Winter FL, Van den Bossche MJA, et al
    Facial expression recognition deficits in frontotemporal dementia and Alzheimer's disease: a meta-analytic investigation of effects of phenotypic variant, task modality, geographical region and symptomatic specificity.
    J Neurol. 2023 Sep 6. doi: 10.1007/s00415-023-11927.
    PubMed     Abstract available
    
    
    
25. CHAN E, Bonifacio GB, Harrison C, Banerjee G, et al
    Domain-specific neuropsychological investigation of CAA with and without intracerebral haemorrhage.
    J Neurol. 2023 Sep 6. doi: 10.1007/s00415-023-11977.
    PubMed     Abstract available
    
    
    
26. DAMSGAARD L, Janbek J, Laursen TM, Waldemar G, et al
    Healthcare utilization prior to a diagnosis of young-onset Alzheimer's disease: a nationwide nested case-control study.
    J Neurol. 2023 Sep 5. doi: 10.1007/s00415-023-11974.
    PubMed     Abstract available
    
    
    July 2023
27. PENA-BAUTISTA C, Alvarez-Sanchez L, Ferrer-Cairols I, Garcia-Valles L, et al
    Assessment of COVID-19 lockdown effect on early Alzheimer Disease progression.
    J Neurol. 2023 Jul 28. doi: 10.1007/s00415-023-11899.
    PubMed     Abstract available
    
    
    
28. MIZUTANI Y, Ohdake R, Tatebe H, Higashi A, et al
    Associations of Alzheimer's-related plasma biomarkers with cognitive decline in Parkinson's disease.
    J Neurol. 2023 Jul 22. doi: 10.1007/s00415-023-11875.
    PubMed     Abstract available
    
    
    
29. SAW AM, Hrastelj J, Robertson NP
    Path from discovery to recovery: therapeutic and diagnostic advances in Alzheimer's dementia.
    J Neurol. 2023 Jul 3. doi: 10.1007/s00415-023-11840.
    PubMed    
    
    
    June 2023
30. KUCIKOVA L, Zeng J, Munoz-Neira C, Muniz-Terrera G, et al
    Genetic risk factors of Alzheimer's Disease disrupt resting-state functional connectivity in cognitively intact young individuals.
    J Neurol. 2023 Jun 26. doi: 10.1007/s00415-023-11809.
    PubMed     Abstract available
    
    
    April 2023
31. LING Y, Yuan S, Huang X, Tan S, et al
    The association of night shift work with the risk of all-cause dementia and Alzheimer's disease: a longitudinal study of 245,570 UK Biobank participants.
    J Neurol. 2023 Apr 6. doi: 10.1007/s00415-023-11672.
    PubMed     Abstract available
    
    
    
32. FERRUCCI R, Cuffaro L, Capozza A, Rosci C, et al
    Brain positron emission tomography (PET) and cognitive abnormalities one year after COVID-19.
    J Neurol. 2023;270:1823-1834.
    PubMed     Abstract available
    
    
    
33. TAYLOR NL, Shine JM
    A whole new world: embracing the systems-level to understand the indirect impact of pathology in neurodegenerative disorders.
    J Neurol. 2023;270:1969-1975.
    PubMed     Abstract available
    
    
    
34. CONSTANTINIDES VC, Tentolouris-Piperas V, Paraskevas GP, Pyrgelis ES, et al
    Hippocampal subfield volumetry in corticobasal syndrome of diverse underlying pathologies.
    J Neurol. 2023;270:2059-2068.
    PubMed     Abstract available
    
    
    March 2023
35. SEMENKOVA A, Piguet O, Johnen A, Schroeter ML, et al
    The Behavioural Dysfunction Questionnaire discriminates behavioural variant frontotemporal dementia from Alzheimer's disease dementia and major depressive disorder.
    J Neurol. 2023 Mar 23. doi: 10.1007/s00415-023-11666.
    PubMed     Abstract available
    
    
    
36. FILIPPI M, Cecchetti G, Cagnin A, Marra C, et al
    Redefinition of dementia care in Italy in the era of amyloid-lowering agents for the treatment of Alzheimer's disease: an expert opinion and practical guideline.
    J Neurol. 2023 Mar 9. doi: 10.1007/s00415-023-11642.
    PubMed     Abstract available
    
    
    February 2023
37. JISKOOT LC, Russell LL, Greaves CV, van Schaik E, et al
    Addition of the FTD Module to the Neuropsychiatric Inventory improves classification of frontotemporal dementia spectrum disorders.
    J Neurol. 2023 Feb 22. doi: 10.1007/s00415-023-11596.
    PubMed     Abstract available
    
    
    
38. CHU H, Huang C, Miao Y, Ren C, et al
    The association of subjective sleep characteristics and plasma biomarkers of Alzheimer's disease pathology in older cognitively unimpaired adults with higher amyloid-beta burden.
    J Neurol. 2023 Feb 20. doi: 10.1007/s00415-023-11626.
    PubMed     Abstract available
    
    
    
39. EDWARDS M, Corkill R
    Disease-modifying treatments in Alzheimer's disease.
    J Neurol. 2023 Feb 16. doi: 10.1007/s00415-023-11602.
    PubMed    
    
    
    January 2023
40. CRETIN B, Philippi N, Bousiges O, Blanc F, et al
    Transient epileptic amnesia: a retrospective cohort study of 127 cases, including CSF amyloid and tau features.
    J Neurol. 2023 Jan 30. doi: 10.1007/s00415-023-11576.
    PubMed     Abstract available
    
    
    
41. FU X, Chu C, Pang Y, Cai H, et al
    A blood mRNA panel that differentiates Alzheimer's disease from other dementia types.
    J Neurol. 2023 Jan 7. doi: 10.1007/s00415-023-11558.
    PubMed     Abstract available
    
    
    December 2022
42. LIAMPAS I, Siokas V, Lyketsos CG, Dardiotis E, et al
    Associations between neuropsychiatric symptoms and incident Alzheimer's dementia in men versus women.
    J Neurol. 2022 Dec 26. doi: 10.1007/s00415-022-11541.
    PubMed     Abstract available
    
    
    
43. FAN Z, Li Z, Zhao S, Chen Y, et al
    Salivary Abeta(1-42) may be a quick-tested biomarker for clinical use in Alzheimer's disease: a meta-analysis.
    J Neurol. 2022 Dec 23. doi: 10.1007/s00415-022-11509.
    PubMed     Abstract available
    
    
    
44. LEOCADI M, Canu E, Paldino A, Agosta F, et al
    Awareness impairment in Alzheimer's disease and frontotemporal dementia: a systematic MRI review.
    J Neurol. 2022 Dec 13. doi: 10.1007/s00415-022-11518.
    PubMed     Abstract available
    
    
    November 2022
45. LI Y, Chen Z, Wang Q, Lv X, et al
    Identification of hub proteins in cerebrospinal fluid as potential biomarkers of Alzheimer's disease by integrated bioinformatics.
    J Neurol. 2022 Nov 18. pii: 10.1007/s00415-022-11476.
    PubMed     Abstract available
    
    
    
46. LOPEZ-ORTIZ S, Lista S, Valenzuela PL, Pinto-Fraga J, et al
    Effects of physical activity and exercise interventions on Alzheimer's disease: an umbrella review of existing meta-analyses.
    J Neurol. 2022 Nov 7. pii: 10.1007/s00415-022-11454.
    PubMed     Abstract available
    
    
    October 2022
47. FERNANDES M, Mari L, Chiaravalloti A, Paoli B, et al
    (18)F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment.
    J Neurol. 2022;269:5356-5367.
    PubMed     Abstract available
    
    
    September 2022
48. ACHENBACH J, Faissner S, Saft C
    Resurrection of sildenafil: potential for Huntington's Disease, too?
    J Neurol. 2022;269:5144-5150.
    PubMed     Abstract available
    
    
    
49. RHODUS EK, Barber J, Kryscio RJ, Abner EL, et al
    Frontotemporal neurofibrillary tangles and cerebrovascular lesions are associated with autism spectrum behaviors in late-life dementia.
    J Neurol. 2022;269:5105-5113.
    PubMed     Abstract available
    
    
    
50. ALTUNA M, Larumbe R, Zelaya MV, Moreno S, et al
    Progressive cognitive impairment and familial spastic paraparesis due to PRESENILIN 1 mutation: anatomoclinical characterization.
    J Neurol. 2022;269:4853-4862.
    PubMed     Abstract available
    
    
    August 2022
51. SINGH NA, Graff-Radford J, Machulda MM, Schwarz CG, et al
    Atypical Alzheimer's disease phenotypes with normal or borderline PET biomarker profiles.
    J Neurol. 2022 Aug 24. pii: 10.1007/s00415-022-11330.
    PubMed     Abstract available
    
    
    
52. DOUNAVI ME, Newton C, Jenkins N, Mak E, et al
    Macrostructural brain alterations at midlife are connected to cardiovascular and not inherited risk of future dementia: the PREVENT-Dementia study.
    J Neurol. 2022;269:4299-4309.
    PubMed     Abstract available
    
    
    July 2022
53. MENARDI A, Dotti L, Ambrosini E, Vallesi A, et al
    Transcranial magnetic stimulation treatment in Alzheimer's disease: a meta-analysis of its efficacy as a function of protocol characteristics and degree of personalization.
    J Neurol. 2022 Jul 4. pii: 10.1007/s00415-022-11236.
    PubMed     Abstract available
    
    
    
54. LAFORCE RJ, Dallaire-Theroux C, Racine AM, Dent G, et al
    Tau positron emission tomography, cerebrospinal fluid and plasma biomarkers of neurodegeneration, and neurocognitive testing: an exploratory study of participants with myotonic dystrophy type 1.
    J Neurol. 2022;269:3579-3587.
    PubMed     Abstract available
    
    
    
55. ROSENBLUM Y, Shiner T, Bregman N, Fahoum F, et al
    Event-related oscillations differentiate between cognitive, motor and visual impairments.
    J Neurol. 2022;269:3529-3540.
    PubMed     Abstract available
    
    
    June 2022
56. CLARK E, Faruque S, Mutebi C, Nagirimadugu NV, et al
    Investigating the relationship between mild traumatic brain injury and Alzheimer's disease and related dementias: a systematic review.
    J Neurol. 2022 Jun 1. pii: 10.1007/s00415-022-11186.
    PubMed     Abstract available
    
    
    March 2022
57. ISELLA V, Crivellaro C, Formenti A, Musarra M, et al
    Validity of cingulate-precuneus-temporo-parietal hypometabolism for single-subject diagnosis of biomarker-proven atypical variants of Alzheimer's Disease.
    J Neurol. 2022 Mar 26. pii: 10.1007/s00415-022-11086.
    PubMed     Abstract available
    
    
    
58. GIACOMUCCI G, Mazzeo S, Bagnoli S, Ingannato A, et al
    Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment.
    J Neurol. 2022 Mar 14. pii: 10.1007/s00415-022-11055.
    PubMed     Abstract available
    
    
    
59. BANERJEE G, Forsgard N, Ambler G, Keshavan A, et al
    Cerebrospinal fluid metallomics in cerebral amyloid angiopathy: an exploratory analysis.
    J Neurol. 2022;269:1470-1475.
    PubMed     Abstract available
    
    
    February 2022
60. CORRIVEAU-LECAVALIER N, Machulda MM, Botha H, Graff-Radford J, et al
    Phenotypic subtypes of progressive dysexecutive syndrome due to Alzheimer's disease: a series of clinical cases.
    J Neurol. 2022 Feb 25. pii: 10.1007/s00415-022-11025.
    PubMed     Abstract available
    
    
    January 2022
61. LARDEUX P, Fourier A, Peter E, Dorey A, et al
    Core cerebrospinal fluid biomarker profile in anti-LGI1 encephalitis.
    J Neurol. 2022;269:377-388.
    PubMed     Abstract available
    
    
    December 2021
62. SCHUMACHER J, Taylor JP, Hamilton CA, Firbank M, et al
    Functional connectivity in mild cognitive impairment with Lewy bodies.
    J Neurol. 2021;268:4707-4720.
    PubMed     Abstract available
    
    
    
63. SANTORO JD, Pagarkar D, Chu DT, Rosso M, et al
    Neurologic complications of Down syndrome: a systematic review.
    J Neurol. 2021;268:4495-4509.
    PubMed     Abstract available
    
    
    November 2021
64. ROSSO M, Chu D
    Gaetano Perusini (1879-1915).
    J Neurol. 2021;268:4400-4401.
    PubMed    
    
    
    October 2021
65. CONTADOR J, Perez-Millan A, Guillen N, Tort-Merino A, et al
    Baseline MRI atrophy predicts 2-year cognitive outcomes in early-onset Alzheimer's disease.
    J Neurol. 2021 Oct 19. pii: 10.1007/s00415-021-10851.
    PubMed     Abstract available
    
    
    
66. PLEEN J, Townley R
    Alzheimer's disease clinical trial update 2019-2021.
    J Neurol. 2021 Oct 5. pii: 10.1007/s00415-021-10790.
    PubMed     Abstract available
    
    
    
67. ARMON C, Wolfson S, Margalit R, Avraham L, et al
    Estimating the X chromosome-mediated risk for developing Alzheimer's disease.
    J Neurol. 2021 Oct 5. pii: 10.1007/s00415-021-10826.
    PubMed     Abstract available
    
    
    
68. OLIVIERI P, Lebouvier T, Hardouin JB, Courtemanche H, et al
    LeSCoD: a new clinical scale for the detection of Lewy body disease in neurocognitive disorders.
    J Neurol. 2021;268:3886-3896.
    PubMed     Abstract available
    
    
    July 2021
69. ULUGUT H, Stek S, Wagemans LEE, Jutten RJ, et al
    The natural history of primary progressive aphasia: beyond aphasia.
    J Neurol. 2021 Jul 3. pii: 10.1007/s00415-021-10689.
    PubMed     Abstract available
    
    
    June 2021
70. MOHAMED AZ, Nestor PJ, Cumming P, Nasrallah FA, et al
    Traumatic brain injury fast-forwards Alzheimer's pathology: evidence from amyloid positron emission tomorgraphy imaging.
    J Neurol. 2021 Jun 30. pii: 10.1007/s00415-021-10669.
    PubMed     Abstract available
    
    
    May 2021
71. LIU X, Dounavi ME, Ritchie K, Wells K, et al
    Higher midlife CAIDE score is associated with increased brain atrophy in a cohort of cognitively healthy middle-aged individuals.
    J Neurol. 2021;268:1962-1971.
    PubMed     Abstract available
    
    
    April 2021
72. WEI Y, Liu M, Wang D
    The propagation mechanisms of extracellular tau in Alzheimer's disease.
    J Neurol. 2021 Apr 28. pii: 10.1007/s00415-021-10573.
    PubMed     Abstract available
    
    
    
73. FIRBANK MJ, O'Brien JT, Durcan R, Allan LM, et al
    Mild cognitive impairment with Lewy bodies: blood perfusion with arterial spin labelling.
    J Neurol. 2021;268:1284-1294.
    PubMed     Abstract available
    
    
    January 2021
74. ORAD RI, Shiner T
    Differentiating dementia with Lewy bodies from Alzheimer's disease and Parkinson's disease dementia: an update on imaging modalities.
    J Neurol. 2021 Jan 29. pii: 10.1007/s00415-021-10402.
    PubMed     Abstract available
    
    
    
75. SEGHEZZO G, Van Hoecke Y, James L, Davoren D, et al
    Feasibility study of assessing the Preclinical Alzheimer Cognitive Composite (PACC) score via videoconferencing.
    J Neurol. 2021 Jan 26. pii: 10.1007/s00415-021-10403.
    PubMed     Abstract available
    
    
    May 2020
76. DONAGHY PC, Firbank M, Mitra D, Petrides G, et al
    Microbleeds in dementia with Lewy bodies.
    J Neurol. 2020;267:1491-1498.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.